stars 1 stars 2 stars 3

Okomera has developed a proprietary technology platform that transforms patient biopsies into multiple miniaturized tumor avatars, enabling rapid assessment of treatment response in real-world conditions. Designed as a decentralized lab for clinicians and biopharma companies, the platform seamlessly converges cutting-edge hardware, software, and biological technologies into a single integrated system, making functional precision medicine accessible at scale. We are building a future where every cancer patient receives the right treatment from the start.

Okomera Questions

Raphaël Tomasi is the Co-founder and VP Platform of Okomera.

21 people are employed at Okomera.

Okomera is based in Paris, Île-de-France.

Top Okomera Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users